Methyl iodide → HCID 58484568, compound
Reaction equation
[CH2:1]([C:3]1[CH:4]=[C:5]([CH3:31])[C:6]([N:9]2[CH2:14][CH2:13][N:12]([C:15]([C:17]3[CH:22]=[CH:21][C:20]([N:23]4[C@H:27]([CH2:28][OH:29])[CH2:26][O:25][C:24]4=[O:30])=[CH:19][CH:18]=3)=[O:16])[CH2:11][CH2:10]2)=[N:7][CH:8]=1)[CH3:2].[CH3:32]I>>[CH2:1]([C:3]1[CH:4]=[C:5]([CH3:31])[C:6]([N:9]2[CH2:10][CH2:11][N:12]([C:15]([C:17]3[CH:22]=[CH:21][C:20]([N:23]4[C@H:27]([CH2:28][O:29][CH3:32])[CH2:26][O:25][C:24]4=[O:30])=[CH:19][CH:18]=3)=[O:16])[CH2:13][CH2:14]2)=[N:7][CH:8]=1)[CH3:2]Participants
3
Procedure
By reaction and treatment in the same manner as in Preparation Example 93 and using (R)-3-{4-[4-(5-ethyl-3-methylpyridin-2-yl)piperazine-1-carbonyl]phenyl}-4-hydroxymethyloxazolidin-2-one (637 mg) described in Example 307 and methyl iodide (255 mg), the title compound (582 mg) was obtained.
Workup
- customBy reaction and treatment in the same manner
- customas in Preparation Example 93
Sources & evidence
- ORD record
- ord-edf2fc4443ea4eb191ca53cdda50b7c1
- Source dataset
- uspto-grants-2013_01
- Patent number
- US08354401B2
Reaction notes
Loading…